CELUCelularity Inc.

CELU Stock Price, Valuation & Chart | Celularity Inc.

Compare

$1.860-0.02 (-1.06%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CELU intrinsic value CELU calculated fair value vs price

Overview Financials Dividends Ratios

CELU Historical price chart

CELU Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization53.84M

PE Ratio-0.52

EPS-3.6

Trading Volume647.19K

Today's High/Low1.96/1.69

Dividend Yield0.00

52 Week High/Low2.65/0.56

Shares Outstanding28.95M

CELU Financial Statement

CELU Analyst ratings

CELU Analysis & performance metrics

CELU Company profile

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and…

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I…

CELU Management team

Name

Position

Carlos Ramirez

SVice President of Investor Relations

Stephen A. Brigido D.P.M.

President of Degenerative Diseases

David Jakob Lemus CPA, M.S., MBA

Treasurer

Tim Wilk

Senior Vice President of Technical Operations

John R. Haines

Senior EVice President, Corporate Secretary, Global Manager & Chief Administrative Officer

Robert Joseph Hariri M.D., Ph.D.CEO

Founder, Chief Executive Officer & Chairman

David C. Beers C.F.A.CFO

Chief Financial Officer

Sharmila Koppisetti M.D.

Senior Vice President of Clinical Dev. Immunology & Drug Safety

Name

Position

Carlos Ramirez

SVice President of Investor Relations

Stephen A. Brigido D.P.M.

President of Degenerative Diseases

David Jakob Lemus CPA, M.S., MBA

Treasurer

Tim Wilk

Senior Vice President of Technical Operations

John R. Haines

Senior EVice President, Corporate Secretary, Global Manager & Chief Administrative Officer

Robert Joseph Hariri M.D., Ph.D.CEO

Founder, Chief Executive Officer & Chairman

David C. Beers C.F.A.CFO

Chief Financial Officer

Sharmila Koppisetti M.D.

Senior Vice President of Clinical Dev. Immunology & Drug Safety

Management Team

Carlos Ramirez

SVice President of Investor Relations

Stephen A. Brigido D.P.M.

President of Degenerative Diseases

David Jakob Lemus CPA, M.S., MBA

Treasurer

Tim Wilk

Senior Vice President of Technical Operations

John R. Haines

Senior EVice President, Corporate Secretary, Global Manager & Chief Administrative Officer

Robert Joseph Hariri M.D., Ph.D.CEO

Founder, Chief Executive Officer & Chairman

David C. Beers C.F.A.CFO

Chief Financial Officer

Sharmila Koppisetti M.D.

Senior Vice President of Clinical Dev. Immunology & Drug Safety

Management

Carlos Ramirez

SVice President of Investor Relations

Stephen A. Brigido D.P.M.

President of Degenerative Diseases

David Jakob Lemus CPA, M.S., MBA

Treasurer

Tim Wilk

Senior Vice President of Technical Operations

John R. Haines

Senior EVice President, Corporate Secretary, Global Manager & Chief Administrative Officer

Robert Joseph Hariri M.D., Ph.D.CEO

Founder, Chief Executive Officer & Chairman

David C. Beers C.F.A.CFO

Chief Financial Officer

Sharmila Koppisetti M.D.

Senior Vice President of Clinical Dev. Immunology & Drug Safety

Total 8 executives

CELU Frequently asked questions

What is Celularity Inc. (CELU) Stock Price?

Current stock price of Celularity Inc. (CELU) stock is $1.860. The stock price is -1.06% lower in the session. The intraday range can be seen from this page. Volume of Celularity Inc. (CELU) stock is 647.19K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Celularity Inc. (CELU) stock price going up or down today?

The stock price of Celularity Inc. (CELU) can change with earnings, company news, and overall market sentiment. Celularity Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Celularity Inc. stock expensive at its current price?

Whether Celularity Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CELU on this page is -0.52. EPS on this page is -3.60. Compare those figures with peers and growth expectations before deciding if the current Celularity Inc. price is justified.

How has the stock price of Celularity Inc. (CELU) performed historically?

Historical performance for Celularity Inc. (CELU) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CELU reacted to past earnings and market events.

Should I buy Celularity Inc. (CELU) stock, at this price?

Buying Celularity Inc. (CELU) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.